OncoNano Medicine
PrivateLast Round
Series C
Sep 23, 2026
Est. Valuation
$60M
Total Funding Raised
$216.27M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
OncoNano Medicine is a biotechnology company that develops pH-activated compounds designed to detect and treat diseased tissue, with a focus on enhancing cancer treatment during surgery and post-operative evaluation.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine, Medical Imaging, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
OncoNano Medicine Comparables
Compare OncoNano Medicine with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| pHLIP, Inc. | 87% | |
| Cybrexa Therapeutics | 84% | |
| Xilio Therapeutics | 74% |
OncoNano Medicine Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series C | Sep 23, 2026 | ||||
| Series B Extension | Jun 2, 2025 | ||||
| Series B | Oct 25, 2021 | ||||
| Series B | Jun 17, 2021 | ||||
| Grant | Aug 20, 2020 | ||||
Grant | Aug 27, 2019 |
OncoNano Medicine Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Advantech Capital | Series B |
| Salem Partners | Series B Extension, Series A |
| Cancer Prevention and Research Institute of Texas | Grant, Series B |
| Cancer Prevention and Research Institute of Texas (CPRIT) | Grant, Series B |
Market signals
Structured signals derived from secondary market and firmographic data.
- Sep 23, 2026
Raised $10M in Series C funding.
- Aug 22, 2026
Monthly visitors grew 96% MoM, reaching 3.1K.
OncoNano Medicine Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about OncoNano Medicine's valuation, stock price, and market status.
Is OncoNano Medicine a public or private company?
OncoNano Medicine is a private company.
What is the current stock price of OncoNano Medicine?
OncoNano Medicine is a private company, so its shares have no public market price. Caplight tracks OncoNano Medicine's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is OncoNano Medicine worth (valuation)?
OncoNano Medicine's valuation is estimated at $60.0M based on funding round data.
Can I buy OncoNano Medicine stock?
OncoNano Medicine shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was OncoNano Medicine's last funding round?
OncoNano Medicine's most recent funding round was Series C on September 23, 2026.
Who are the main investors in OncoNano Medicine?
Key investors in OncoNano Medicine include Advantech Capital, Salem Partners, Cancer Prevention and Research Institute of Texas.
Will OncoNano Medicine IPO soon?
No public IPO plans have been announced for OncoNano Medicine.
How can I track OncoNano Medicine secondary market activity?
Caplight tracks bids, offers, and trades in OncoNano Medicine's shares on secondary markets.